Jun 17, 2024
CHEMISTREE ANNOUNCES NAME CHANGE AND SHARE CONSOLIDATION
May 03, 2024
Chemistree Directors Ratify Debenture Restructuring
Apr 30, 2024
CHEMISTREE ANNOUNCES RESULTS FROM ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS
Apr 26, 2024
CHEMISTREE DEBENTUREHOLDERS APPROVE DEBT RESTRUCTURING
Mar 14, 2024
CHEMISTREE TO SEEK DEBENTUREHOLDER APPROVAL FOR DEBT RESTRUCTURING
Feb 08, 2021
Chemistree Investee - ImmunoFlex Receives NRC IRAP Funding
Jan 19, 2021
Chemistree Investee ImmunoFlex Receives Health Canada Approval For Flex 10 Product
Oct 30, 2020
Chemistree Completes Review and Amendment of Investment Policy
Aug 05, 2020
Chemistree Completes Expansion of Sugarleaf Facility
Jul 09, 2020
Chemistree Closes First Tranche Of Immunoflex Investment
Jun 18, 2020
Chemistree Details Immunoflex Investment
Jun 15, 2020
Chemistree to invest up to $1 million in cannabinoid-linked biotech venture
Jun 08, 2020
Chemistree Provides Washington State and General Corporate Update
Apr 09, 2020
Chemistree Updates Strategic Review Initiatives - Grants Incentive Stock Options
Apr 02, 2020
Chemistree Provides Sugarleaf - Washington Update COVID-19 Response and Operations Update
Jan 10, 2020
Chemistree to Unveil VR Tour of Sugarleaf Facility at Lift - Vancouver
Oct 07, 2019
Chemistree Cancels PCCBD Investment
Sep 26, 2019
Chemistree Applauds Initial Success for Safe Banking Act in U.S.
Sep 24, 2019
Chemistree Provides Washington State Update from Sugarleaf
Jul 22, 2019
Chemistree Completes Investment in New Jersey Cannabis Applicant - ACS